Neuronetics

Update in progress

STIM (NasdaqGM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Neuronetics, Inc. provides in-office treatments for neurohealth conditions in the United States and abroad. Its flagship NeuroStar Advanced Therapy System offers non-invasive, office-based transcranial magnetic stimulation to adults with major depressive disorder. The device uses MRI-strength magnetic pulses to stimulate brain regions linked to mood. Sales target psychiatrists through a dedicated support team. Founded in 2001, based in Malvern, Pennsylvania.

Company score

Sentiment: 0.11; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.05; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.00; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.01; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.06; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive